|
gold |
39 |
|
platinum |
36 |
|
humans |
31 |
|
organic light-emitting diodes |
25 |
|
luminescence |
24 |
|
hepatocellular carcinoma |
22 |
|
phosphorescence |
22 |
|
n-heterocyclic carbenes |
20 |
|
proteomics |
20 |
|
apoptosis |
19 |
|
gold - chemistry |
18 |
|
ruthenium |
18 |
|
palladium |
17 |
|
photochemistry |
17 |
|
porphyrinoids |
17 |
|
self-assembly |
16 |
|
silver |
16 |
|
animals |
15 |
|
homogeneous catalysis |
15 |
|
nanostructures |
15 |
|
antitumor agents |
14 |
|
apoptosis - drug effects |
14 |
|
n-heterocyclic carbene |
14 |
|
cell line, tumor |
13 |
|
iron |
13 |
|
metal-metal interactions |
13 |
|
ruthenium - chemistry |
13 |
|
catalysis |
12 |
|
density functional calculations |
12 |
|
ligands |
12 |
|
mice |
12 |
|
molecular structure |
12 |
|
nasopharyngeal carcinoma |
12 |
|
oxidation |
12 |
|
thermally activated delayed fluorescence |
12 |
|
water - chemistry |
12 |
|
cancer |
11 |
|
cytotoxicity |
11 |
|
c−h activation |
11 |
|
iridium |
11 |
|
organic light-emitting devices |
11 |
|
photocatalysis |
11 |
|
photophysics |
11 |
|
supramolecular chemistry |
11 |
|
tetradentate ligands |
11 |
|
tungsten |
11 |
|
alkenes - chemistry |
10 |
|
autophagy - drug effects |
10 |
|
cyclometalation |
10 |
|
diazo compounds |
10 |
|
dna |
10 |
|
electroluminescence |
10 |
|
female |
10 |
|
ligand effects |
10 |
|
macrocyclic ligands |
10 |
|
n ligands |
10 |
|
nanoparticles |
10 |
|
oxidation-reduction |
10 |
|
adult |
9 |
|
aurophilicity |
9 |
|
carbenes |
9 |
|
cells, cultured |
9 |
|
cisplatin |
9 |
|
copper |
9 |
|
crystallography, x-ray |
9 |
|
gels |
9 |
|
luminescent measurements |
9 |
|
male |
9 |
|
metalloporphyrins - pharmacology |
9 |
|
models, molecular |
9 |
|
noncovalent interactions |
9 |
|
oleds |
9 |
|
platinum complexes |
9 |
|
platinum(ii) complexes |
9 |
|
porphyrin |
9 |
|
rats |
9 |
|
rhodium |
9 |
|
spectrometry, mass, matrix-assisted laser desorption-ionization |
9 |
|
spectrophotometry, ultraviolet |
9 |
|
thermally activated delayed fluorescence (tadf) |
9 |
|
antineoplastic activity |
8 |
|
asymmetric catalysis |
8 |
|
carbon - chemistry |
8 |
|
coordination complexes - chemistry - toxicity |
8 |
|
electrophosphorescence |
8 |
|
galectin-1 |
8 |
|
ligand-to-ligand charge transfer |
8 |
|
light |
8 |
|
metal–metal interactions |
8 |
|
mir-22 |
8 |
|
otx008 |
8 |
|
platinum complex |
8 |
|
porphyrins - chemistry |
8 |
|
semiconductors |
8 |
|
stereoisomerism |
8 |
|
structure elucidation |
8 |
|
tetradentate pt(ii) complexes |
8 |
|
therapeutics |
8 |
|
thiol reactivity |
8 |
|
white emission |
8 |
|
acetylides |
7 |
|
acrosome - physiology |
7 |
|
amines |
7 |
|
amino acid sequence |
7 |
|
antineoplastic agents - chemistry - pharmacology |
7 |
|
bioinorganic chemistry |
7 |
|
coordination complexes - chemistry |
7 |
|
drug screening assays, antitumor |
7 |
|
enantioselectivity |
7 |
|
endoplasmic reticulum - drug effects - pathology |
7 |
|
energy transfer |
7 |
|
fluorescence |
7 |
|
gold(iii) compound |
7 |
|
high efficiency |
7 |
|
hydroxylation |
7 |
|
in situ hybridization, fluorescence |
7 |
|
intermolecular interactions |
7 |
|
metal nanoparticles - chemistry |
7 |
|
metallacycles |
7 |
|
metalloporphyrins - chemistry |
7 |
|
mitochondria |
7 |
|
models, chemical |
7 |
|
molecular sequence data |
7 |
|
nitrides |
7 |
|
oled |
7 |
|
organogold compounds - chemistry - pharmacology |
7 |
|
phosphines - chemistry |
7 |
|
physics engineering |
7 |
|
porphyrins |
7 |
|
protein structure, tertiary |
7 |
|
proteins - genetics - metabolism |
7 |
|
schiff bases |
7 |
|
sequence alignment |
7 |
|
signal transduction - drug effects |
7 |
|
spermatogenesis - physiology |
7 |
|
spermatozoa - cytology - metabolism |
7 |
|
testis - cytology - physiology |
7 |
|
tissue distribution |
7 |
|
wound healing |
7 |
|
zinc fingers |
7 |
|
amidation |
6 |
|
antineoplastic agents - pharmacology |
6 |
|
autolysosome |
6 |
|
autophagosome |
6 |
|
breast cancer |
6 |
|
c(sp2)−c(sp2) bond |
6 |
|
c-h bond |
6 |
|
carbenoids |
6 |
|
caspase 3 - metabolism |
6 |
|
cell line |
6 |
|
chemocytotoxic |
6 |
|
cholestenones - pharmacology |
6 |
|
clathrin light chain a |
6 |
|
color-tunable |
6 |
|
cyclization |
6 |
|
dna - chemistry - metabolism |
6 |
|
electronic structure |
6 |
|
fibroblasts |
6 |
|
fibroblasts - cytology - drug effects |
6 |
|
flux |
6 |
|
g quadruplexes |
6 |
|
gene expression regulation, neoplastic - drug effects |
6 |
|
gold - chemistry - pharmacology |
6 |
|
growth arrest and dna damage (gadd) inducible genes |
6 |
|
keratinocytes |
6 |
|
keratinocytes - cytology - drug effects |
6 |
|
kinetics |
6 |
|
lc3 |
6 |
|
lysosome |
6 |
|
membrane potential, mitochondrial - drug effects |
6 |
|
mice, inbred balb c |
6 |
|
molecular wheels |
6 |
|
nanoparticles - therapeutic use |
6 |
|
organic light emitting diodes |
6 |
|
organometallic compounds - chemistry |
6 |
|
organoplatinum compounds - chemistry |
6 |
|
osmium |
6 |
|
phagophore |
6 |
|
photoluminescence |
6 |
|
platinum - chemistry |
6 |
|
porphyrins - chemistry - metabolism - pharmacology |
6 |
|
reactive oxygen species - metabolism |
6 |
|
sarcoplasmic reticulum calcium-transporting atpases - antagonists and inhibitors |
6 |
|
silver - therapeutic use |
6 |
|
small extracellular vesicles |
6 |
|
solution process |
6 |
|
spectrum analysis |
6 |
|
spin-orbit coupling |
6 |
|
stress |
6 |
|
tadf |
6 |
|
vacuole |
6 |
|
wound healing - drug effects |
6 |
|
1/f noise |
5 |
|
2-de |
5 |
|
acetaldehyde - analogs & derivatives - metabolism |
5 |
|
acetone - chemistry |
5 |
|
acetylide |
5 |
|
acyl coenzyme a - metabolism |
5 |
|
adducts |
5 |
|
adiponectin |
5 |
|
adipose tissue |
5 |
|
adolescent |
5 |
|
affinity chromatography |
5 |
|
aged |
5 |
|
aggregation forms |
5 |
|
aging |
5 |
|
aging - metabolism |
5 |
|
alkenes |
5 |
|
amination |
5 |
|
amines - chemistry |
5 |
|
antibacterial agents |
5 |
|
anticancer |
5 |
|
antimutagenic agents - pharmacology |
5 |
|
antineoplastic agents - chemical synthesis - pharmacology |
5 |
|
atp |
5 |
|
autophagy |
5 |
|
aza compounds - chemistry |
5 |
|
aziridination |
5 |
|
bioaccumulation |
5 |
|
biotin |
5 |
|
bipolar organic host |
5 |
|
blotting, western |
5 |
|
carcinoma, hepatocellular - metabolism - pathology |
5 |
|
caspases - metabolism |
5 |
|
catechin - analogs & derivatives - pharmacology |
5 |
|
cell imaging |
5 |
|
charge transfer |
5 |
|
chemical bonds |
5 |
|
chemical model reactions |
5 |
|
child |
5 |
|
china |
5 |
|
chlorine compounds |
5 |
|
cohort studies |
5 |
|
color‐tunable |
5 |
|
cyclopropanation reaction |
5 |
|
cytokines |
5 |
|
deep-red emission |
5 |
|
device lifetime |
5 |
|
dna damage |
5 |
|
drug delivery |
5 |
|
dual fluorescence–phosphorescence |
5 |
|
e. coli |
5 |
|
electrochemistry |
5 |
|
electrophoresis, gel, two-dimensional |
5 |
|
enox2 |
5 |
|
epigallocatechin gallate peracetate |
5 |
|
escherichia coli - genetics |
5 |
|
fluorenes |
5 |
|
food contamination |
5 |
|
gan epilayers |
5 |
|
genipin |
5 |
|
glycosylation |
5 |
|
gold compounds - pharmacology |
5 |
|
gold porphyrin |
5 |
|
gold(iii) |
5 |
|
gold(iii) porphyrin 1a |
5 |
|
groundwater hydraulics |
5 |
|
heat-shock protein |
5 |
|
heat-shock proteins - metabolism |
5 |
|
hela cells |
5 |
|
hepatitis b virus |
5 |
|
hsp27 heat-shock proteins |
5 |
|
hsp70 heat-shock proteins - metabolism |
5 |
|
hydrogen - metabolism |
5 |
|
hydrogen bondings |
5 |
|
hydrogen production |
5 |
|
idronoxil |
5 |
|
imidazoles - metabolism |
5 |
|
interaction profiling |
5 |
|
intercalating agents - chemical synthesis - pharmacology |
5 |
|
ionization time of flight mass spectrometry |
5 |
|
ire1α |
5 |
|
iron - chemistry |
5 |
|
kidney calculi - etiology - urine |
5 |
|
kinetic control |
5 |
|
liquid chromatography-tan-dem mass spectrometry |
5 |
|
liver - drug effects - injuries - metabolism |
5 |
|
liver - metabolism |
5 |
|
liver glycogen - metabolism |
5 |
|
liver injury |
5 |
|
liver neoplasms - metabolism - pathology |
5 |
|
longevity regulator |
5 |
|
low-permeability layer |
5 |
|
luminescent agents - chemistry |
5 |
|
lung cancer |
5 |
|
lysosomal proteolysis |
5 |
|
macrocyclic compounds - chemical synthesis |
5 |
|
mammary neoplasms, experimental - drug therapy |
5 |
|
materials science |
5 |
|
matrix-assisted laser desorption |
5 |
|
medicinal chemistry |
5 |
|
membrane potential |
5 |
|
memory t-cells |
5 |
|
metal-alkynyl complexes |
5 |
|
metallophilic interactions |
5 |
|
methane - analogs & derivatives - chemistry |
5 |
|
methane - analogs and derivatives - chemistry |
5 |
|
microwave synthesis |
5 |
|
middle aged |
5 |
|
mitochondrial proteins - genetics - metabolism |
5 |
|
molecular chaperones - metabolism |
5 |
|
molecular conformation |
5 |
|
multinodular goiter |
5 |
|
multiphase flow |
5 |
|
mutagens - metabolism |
5 |
|
möbius strip |
5 |
|
near-infrared emission |
5 |
|
neoplasm proteins - metabolism |
5 |
|
nf-κb |
5 |
|
olefins |
5 |
|
organic light‐emitting diodes |
5 |
|
organogold compounds - chemistry |
5 |
|
organometallic compounds - chemical synthesis - chemistry |
5 |
|
osmium - chemistry |
5 |
|
outer membrane proteins |
5 |
|
p ligands |
5 |
|
phenylacetaldehyde |
5 |
|
phip |
5 |
|
photochemical reactions |
5 |
|
photooxidation |
5 |
|
phytoestrogen |
5 |
|
porphyrin derivative |
5 |
|
prognosis |
5 |
|
proliferation |
5 |
|
protein binding |
5 |
|
protein interaction mapping - methods |
5 |
|
protein staining |
5 |
|
proteins - metabolism |
5 |
|
proteome - metabolism |
5 |
|
quantum theory |
5 |
|
quinoneimido complexes |
5 |
|
recombinant proteins - genetics - metabolism |
5 |
|
redox reactions |
5 |
|
rosiglitazone |
5 |
|
sand box |
5 |
|
schiff base complexes |
5 |
|
sensitivity and specificity |
5 |
|
shotgun proteomics |
5 |
|
signaling pathway analysis |
5 |
|
silver - chemistry |
5 |
|
silver ions |
5 |
|
silver nanoparticles |
5 |
|
single emitters |
5 |
|
sirt1 |
5 |
|
sirtuin 1 |
5 |
|
sirtuin 3 |
5 |
|
sirtuins - genetics - metabolism |
5 |
|
spectrometry, mass, electrospray ionization - methods |
5 |
|
surface plasmon resonance absorption |
5 |
|
surface properties |
5 |
|
terpyridine |
5 |
|
thiazolidinediones - toxicity |
5 |
|
timosaponin aiii |
5 |
|
tmt labeling |
5 |
|
transcription factor yy1 |
5 |
|
transcriptomics |
5 |
|
transition metal complexes |
5 |
|
trefoil knots |
5 |
|
triazines - analysis - chemistry - urine |
5 |
|
triplet state |
5 |
|
ttf1 |
5 |
|
tumor markers, biological - metabolism |
5 |
|
tumour-associated macrophage |
5 |
|
unconfined aquifer |
5 |
|
uncoupling protein 2 |
5 |
|
up-regulation |
5 |
|
uv/vis spectroscopy |
5 |
|
venous infiltration |
5 |
|
xiap |
5 |
|
aatitumor agents |
4 |
|
acylnitrene transfer |
4 |
|
aldehydes - chemistry |
4 |
|
alkyne ligands |
4 |
|
alkynes - chemistry |
4 |
|
and light-emitting devices |
4 |
|
anemarrhena - chemistry |
4 |
|
angiogenesis inhibitors - chemistry - pharmacology |
4 |
|
animal experiment |
4 |
|
anti-hiv agents - chemistry - pharmacology |
4 |
|
anticancer agents |
4 |
|
anticancer compounds |
4 |
|
antigens, viral - immunology |
4 |
|
antimetastasis |
4 |
|
antineoplastic agents - chemical synthesis - chemistry - pharmacology |
4 |
|
antineoplastic agents - chemistry - therapeutic use - toxicity |
4 |
|
antineoplastic agents - chemistry - toxicity |
4 |
|
antineoplastic agents - therapeutic use |
4 |
|
antineoplastic agents, phytogenic - pharmacology |
4 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
4 |
|
apoptosis - drug effects - physiology |
4 |
|
apoptosis regulatory proteins - genetics |
4 |
|
asparagine synthetase |
4 |
|
azo compounds - chemistry |
4 |
|
bacterial metal resistance |
4 |
|
biofilm |
4 |
|
bioinformatics |
4 |
|
biological targets |
4 |
|
biomarkers |
4 |
|
biosensing techniques - methods |
4 |
|
blue electroluminescence |
4 |
|
bond theory |
4 |
|
boronic esters |
4 |
|
breast carcinogenesis |
4 |
|
c-c bonds |
4 |
|
c-h activation |
4 |
|
c-h insertion |
4 |
|
capping actin protein gelsolin-like |
4 |
|
carbene-metal-amide (cma) |
4 |
|
carbene–metal–amide |
4 |
|
carcinoma - drug therapy |
4 |
|
carcinoma - drug therapy - mortality |
4 |
|
carcinoma, non-small-cell lung - genetics - metabolism - pathology |
4 |
|
caries |
4 |
|
caries arrest |
4 |
|
cariogenic |
4 |
|
catalase - metabolism |
4 |
|
catalyse |
4 |
|
catalyst activity |
4 |
|
catenanes |
4 |
|
cd137 |
4 |
|
cd8+ t cells |
4 |
|
cd8-positive t-lymphocytes - immunology |
4 |
|
cell cycle - drug effects |
4 |
|
cell cycle arrest |
4 |
|
cell differentiation |
4 |
|
cell fractionation |
4 |
|
cell migration |
4 |
|
cell movement - drug effects |
4 |
|
chalcogenolates |
4 |
|
charge-carrier mobility |
4 |
|
chemical proteomics |
4 |
|
chemical stability |
4 |
|
chemistry |
4 |
|
chemotherapeutics |
4 |
|
chlorinated solvent |
4 |
|
cisplatin - therapeutic use |
4 |
|
colon cancer |
4 |
|
colonic neoplasms - drug therapy |
4 |
|
color purity |
4 |
|
columnar structures |
4 |
|
complexes |
4 |
|
contact ion pairs |
4 |
|
controlled study |
4 |
|
coordination complexes - chemistry - therapeutic use - toxicity |
4 |
|
copper complexes |
4 |
|
copper(i) emitter |
4 |
|
cross coupling reactions |
4 |
|
cross-coupling reactions |
4 |
|
crystalline samples |
4 |
|
cyclic amines |
4 |
|
cyclosporine - pharmacology |
4 |
|
cysteine thiol conjugation |
4 |
|
cytochromes c - metabolism |
4 |
|
cytotoxicity, immunologic |
4 |
|
c−n bond formation |
4 |
|
dentine |
4 |
|
device fabrication |
4 |
|
dft calculation |
4 |
|
dielectric |
4 |
|
diosgenin - analogs & derivatives - pharmacology |
4 |
|
dna binding |
4 |
|
dna fragmentation - drug effects |
4 |
|
dna recognition |
4 |
|
dna, neoplasm - drug effects - metabolism |
4 |
|
efflux pump |
4 |
|
electroluminescence measurements |
4 |
|
emission quantum yield |
4 |
|
endocytosis |
4 |
|
endoplasmic reticulum - metabolism |
4 |
|
energy up-conversion |
4 |
|
enzyme inhibitors - chemical synthesis |
4 |
|
enzyme-linked immunosorbent assay |
4 |
|
escherichia coli |
4 |
|
exciplex emission |
4 |
|
excitation light |
4 |
|
field-effect |
4 |
|
flow cytometry |
4 |
|
fluoride |
4 |
|
g-quadruplex dna |
4 |
|
g-quadruplexes |
4 |
|
g-quadruplexes - drug effects |
4 |
|
gene expression profiling - methods |
4 |
|
girdin |
4 |
|
gold (iii) |
4 |
|
gold - administration & dosage |
4 |
|
gold - pharmacology |
4 |
|
gold porphyrins |
4 |
|
gold(i) |
4 |
|
gold(i) emitters |
4 |
|
heat-shock proteins - genetics - metabolism |
4 |
|
herpesvirus 4, human - immunology |
4 |
|
heterocyclic compounds - chemistry |
4 |
|
hfo2 dielectrics |
4 |
|
high k |
4 |
|
high quality |
4 |
|
highly efficient oleds |
4 |
|
hiv reverse transcriptase - antagonists & inhibitors |
4 |
|
hiv-1 - physiology |
4 |
|
hsp60 |
4 |
|
hybrid |
4 |
|
hydroarylation |
4 |
|
immune checkpoint inhibitors |
4 |
|
immune-related adverse effects |
4 |
|
in situ nick-end labeling |
4 |
|
inflammation |
4 |
|
inhibitors |
4 |
|
intercellular communication |
4 |
|
invasion |
4 |
|
iron compounds |
4 |
|
isoxazoles - chemical synthesis |
4 |
|
laser spectroscopy |
4 |
|
ligand reactivity |
4 |
|
luminescence conversion |
4 |
|
luminescent probes |
4 |
|
lung neoplasms - genetics - metabolism - pathology |
4 |
|
lymphocyte activation - immunology |
4 |
|
macrocycles |
4 |
|
macrocyclic compounds - chemistry |
4 |
|
macrophages |
4 |
|
magnetic resonance spectroscopy |
4 |
|
manganese |
4 |
|
melanoma, experimental - drug therapy - mortality |
4 |
|
membrane proteins - genetics |
4 |
|
metabolism |
4 |
|
metal ions |
4 |
|
metallodrugs |
4 |
|
metalloporphyrins - adverse effects - pharmacology - therapeutic use |
4 |
|
metalloporphyrins - pharmacology - therapeutic use |
4 |
|
metal–metal closed-shell interaction |
4 |
|
metastasis |
4 |
|
mitochondria - drug effects - metabolism - physiology |
4 |
|
mitochondria - metabolism |
4 |
|
molecular chaperones - genetics - metabolism |
4 |
|
molecular electronics |
4 |
|
monochromic emission |
4 |
|
nanowires |
4 |
|
nasopharyngeal carcinoma (npc) |
4 |
|
nasopharyngeal neoplasms - blood supply - drug therapy - enzymology - pathology |
4 |
|
nasopharyngeal neoplasms - drug therapy |
4 |
|
natural products |
4 |
|
neoplasm |
4 |
|
neoplasm transplantation |
4 |
|
neovascularization, pathologic - prevention and control |
4 |
|
neuroblastoma |
4 |
|
nf-kappa b - immunology - metabolism |
4 |
|
nitrene transfer |
4 |
|
nitrogen ligands |
4 |
|
non-linear optical properties |
4 |
|
nucleobases |
4 |
|
ofet (organic field-effect transistor) |
4 |
|
onogenes |
4 |
|
operational lifetime |
4 |
|
organic |
4 |
|
organic light-emitting device |
4 |
|
organic light-emitting devices (oleds) |
4 |
|
organic light-emitting devices(oleds) |
4 |
|
organic light-emitting diode (oled) |
4 |
|
organic solar cells |
4 |
|
organic thin-film transistor (otft) |
4 |
|
organic thin-film transistors |
4 |
|
organogold compounds - chemical synthesis - pharmacology |
4 |
|
organometallic compounds - chemistry - pharmacology |
4 |
|
organoplatinum compounds - chemistry - metabolism - pharmacology |
4 |
|
otft |
4 |
|
oxalates - chemistry - pharmacology |
4 |
|
oxidative stress - drug effects |
4 |
|
palladium(ii) |
4 |
|
patient-derived xenografts |
4 |
|
pauli repulsion |
4 |
|
pentacene |
4 |
|
pentacene thin-film transistors |
4 |
|
peptides - chemistry |
4 |
|
phosphorescent materials |
4 |
|
phosphorescent platinum(ii) materials |
4 |
|
pi interactions |
4 |
|
pincer ligands |
4 |
|
pitstop 2 |
4 |
|
platinum compounds - chemistry - pharmacology |
4 |
|
platinum(ii) porphyrin |
4 |
|
platinum(ii) schiff base complex |
4 |
|
platinum(ii) α-diimine arylacetylide complexes |
4 |
|
polarization dependence |
4 |
|
polymer |
4 |
|
polymer light-emitting devices |
4 |
|
polymers |
4 |
|
porphyrins - administration & dosage |
4 |
|
porphyrins - chemical synthesis - chemistry |
4 |
|
porphyrins - chemistry - pharmacology |
4 |
|
powder diffraction |
4 |
|
premetastatic niche |
4 |
|
protein 14-3-3 |
4 |
|
protein kinase b |
4 |
|
proteomics - methods |
4 |
|
proto-oncogene proteins c-myc - chemistry - genetics - metabolism |
4 |
|
pyrazoles - chemistry |
4 |
|
reactive intermediates |
4 |
|
red |
4 |
|
rna, messenger - biosynthesis - genetics |
4 |
|
rna, small interfering - genetics |
4 |
|
rocking curves |
4 |
|
ruthenium - chemistry - pharmacology |
4 |
|
ruv-imido complex |
4 |
|
saponin |
4 |
|
saponins - pharmacology |
4 |
|
schiff bases - chemistry - metabolism - pharmacology |
4 |
|
sensors |
4 |
|
silver - analysis |
4 |
|
silver diamine fluoride |
4 |
|
solubility |
4 |
|
solvents - chemistry |
4 |
|
spatial |
4 |
|
structure-activity relationship |
4 |
|
substrate specificity |
4 |
|
sulfuric acids - chemistry |
4 |
|
superoxide dismutase - metabolism |
4 |
|
t-lymphocytes - virology |
4 |
|
t-lymphocytes, cytotoxic - immunology |
4 |
|
tetradentate |
4 |
|
tetradentate o^n^c^n ligand |
4 |
|
thermal proteome profiling |
4 |
|
thermally-activated delayed fluorescence (tadf) |
4 |
|
thioredoxin reductase (trxr) |
4 |
|
tissue-specific immune microenvironment |
4 |
|
topoisomerase i |
4 |
|
toxicity |
4 |
|
transcription factor chop - genetics - metabolism |
4 |
|
transcription factors |
4 |
|
transition-metal-free reaction |
4 |
|
treatment outcome |
4 |
|
tridentate ligands |
4 |
|
tridentate pt(ii) complexes |
4 |
|
trifluoromethyl |
4 |
|
triplet emitter |
4 |
|
triplet emitters |
4 |
|
trisubstituted alkenes |
4 |
|
tuberculosis reactivation |
4 |
|
tumor necrosis factor-alpha - immunology - metabolism |
4 |
|
tumor suppressor protein p53 - genetics - metabolism |
4 |
|
two-photon absorption |
4 |
|
vascular permeability |
4 |
|
vimentin |
4 |
|
viral matrix proteins - chemistry - immunology |
4 |
|
virus replication - drug effects |
4 |
|
volatilization |
4 |
|
white |
4 |
|
x-ray diffraction |
4 |
|
xenograft model antitumor assays |
4 |
|
yellow |
4 |
|
2d magnet |
3 |
|
2d semiconductor |
3 |
|
3d printing |
3 |
|
[60]fullerene |
3 |
|
a. inorganic compounds |
3 |
|
a. nanostructures |
3 |
|
acacia |
3 |
|
acidic vapor |
3 |
|
aerobic oxidation |
3 |
|
agnps. nanostructures |
3 |
|
akt |
3 |
|
albumins - chemistry |
3 |
|
alkadienes - chemistry |
3 |
|
alkenes - chemical synthesis - chemistry |
3 |
|
alkyne |
3 |
|
alkynes |
3 |
|
allenes |
3 |
|
alzheimer disease - metabolism - prevention & control |
3 |
|
amide |
3 |
|
amides - chemical synthesis |
3 |
|
amides - chemistry |
3 |
|
amines - chemical synthesis - chemistry |
3 |
|
amyloid beta-peptides - metabolism |
3 |
|
angiogenesis inhibitors - chemical synthesis - chemistry - pharmacology |
3 |
|
anthracene crystal |
3 |
|
anti-cancer agents |
3 |
|
anti-cancer mechanisms |
3 |
|
anticancer drug |
3 |
|
antimanic agents - pharmacology |
3 |
|
arabinogalactan-protein |
3 |
|
arenes |
3 |
|
arylamine |
3 |
|
asymmetric |
3 |
|
atom/group transfer |
3 |
|
attractive strategies |
3 |
|
azides |
3 |
|
azides - chemistry |
3 |
|
band edge |
3 |
|
beta-amyloid |
3 |
|
biaryls |
3 |
|
bio-inspired catalysts |
3 |
|
bioactive compounds |
3 |
|
biological activities |
3 |
|
biological products - chemistry - pharmacology |
3 |
|
biological reductions |
3 |
|
bipyridines |
3 |
|
bis(η 6-diphenylphosphinobenzene)chromium |
3 |
|
blotting, western - methods |
3 |
|
brain - drug effects - metabolism |
3 |
|
bridging ligands |
3 |
|
burkholderia cepacia |
3 |
|
c-n bond formations |
3 |
|
c. electron microscopy |
3 |
|
c. x-ray diffraction |
3 |
|
camptothecin |
3 |
|
carbene ligands |
3 |
|
carbenoid transfer reactions |
3 |
|
caspase 3 |
3 |
|
caspase 9 - metabolism |
3 |
|
caspases |
3 |
|
cdse/zns quantum dots |
3 |
|
chelating s-ligands |
3 |
|
chelating units |
3 |
|
chemical parameter |
3 |
|
chemical vapour deposition |
3 |
|
chemoselectivity |
3 |
|
chirality |
3 |
|
chirality transfer |
3 |
|
chlorine - chemistry |
3 |
|
chromophores |
3 |
|
cie coordinates |
3 |
|
cis-dihydroxylation |
3 |
|
cleavage reactions |
3 |
|
cluster compounds |
3 |
|
cobalt |
3 |
|
